Sleep drug trial aims to tame suicidal thoughts in veterans
NCT ID NCT06854224
Summary
This study is testing if a medication called suvorexant, which affects brain chemicals related to sleep and alertness, is safe and tolerable for veterans with major depression and a high risk of suicide. Over four weeks, 30 participants will take the drug and complete various computer tasks and questionnaires to measure changes in suicidal thoughts, aggression, and attention. The main goal is to see if this approach is feasible before larger studies can test if it actually helps reduce suicide risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
James J. Peters Veterans Affairs Medical Center
RECRUITINGThe Bronx, New York, 10468, United States
Conditions
Explore the condition pages connected to this study.